1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )TABLE 1:Estimated concentrations (mmol/l) from LCModel fit
Metabolite Hamartoma Thalamus Amygdala NAA 6.28 (12) *9.22 (9) 6.12 (12) Cho 1.87 (10) **1.29 (12) 1.93 (11) Cr 5.31 (14) 6.17 (12) 5.71 (13) MI 10.5 (8) *3.1 (20) *6.0 (12) Glx 9.5 (25) 7.7 (22) 10.1 (21) NAA/Cho† 3.36 (15) *7.15 (14) 3.17 (16) NAA/Cr† 1.18 (18) **1.49 (15) 1.07 (17) Cho/Cr† 0.35 (15) 0.21 (18) 0.34 (19)
Note.—The numbers in parentheses are the estimated LCModel SD expressed as percentages of the estimated concentrations.
* Value differs significantly from that of the hamartoma (no overlaping of the 95% confidence intervals [ie, t > 3.9; P < 0.001])
** P < .02.
† The calculated ratios represent concentration ratios and not ratios of peak areas; effects of T2 are negligible, because of the short TE. The SDs of the ratios were derived from the SD of the concentrations by error multiplication.